Search alternatives:
significantly improve » significantly improved (Expand Search)
significantly linked » significantly longer (Expand Search), significantly altered (Expand Search), significantly higher (Expand Search)
improve decrease » improve disease (Expand Search), improved urease (Expand Search), improves disease (Expand Search)
linked decrease » marked decrease (Expand Search), linear decrease (Expand Search)
Showing 261 - 280 results of 6,722 for search '(( significantly linked decrease ) OR ( significantly improve decrease ))', query time: 0.39s Refine Results
  1. 261
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 262
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 263
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 264
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 265
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 266
    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.

    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 267
    Trends in full immunization coverage among two-year-olds in Sierra Leone, 2008-2019.

    Trends in full immunization coverage among two-year-olds in Sierra Leone, 2008-2019. by Umaru Sesay (18982263)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 268
    Inequalities in full immunization coverage among two-year-olds in Sierra Leone, 2008-2019.

    Inequalities in full immunization coverage among two-year-olds in Sierra Leone, 2008-2019. by Umaru Sesay (18982263)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 269
    Trends in full immunization coverage among two-year-olds in Sierra Leone, 2008-2019.

    Trends in full immunization coverage among two-year-olds in Sierra Leone, 2008-2019. by Umaru Sesay (18982263)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 270
    Characteristics of census tracts that are projected to have high (groups: 250-399 and 400+) and low (groups: 50-99 and 100-249) MHC utilization for COVID-19 vaccination before March 31, 2021. Median values with IQR and p-values for significance difference in the medians are provided.

    Characteristics of census tracts that are projected to have high (groups: 250-399 and 400+) and low (groups: 50-99 and 100-249) MHC utilization for COVID-19 vaccination before Marc... by Fatih Gezer (21485468)

    Published 2025
    Save to List
    Saved in:
  11. 271
    MXene/Bi<sub>2</sub>O<sub>3</sub> Nanocomposites as Supercapacitors for Portable Electronic Devices

    MXene/Bi<sub>2</sub>O<sub>3</sub> Nanocomposites as Supercapacitors for Portable Electronic Devices by Nanasaheb M. Shinde (8560572)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 272
    CBCHCV rawdata. This file contains the raw dataset used in the analysis of decreased levels of inflammatory markers in patients with hepatitis C virus (HCV) infection. The dataset includes variables such as demographic characteristics, clinical indicators, and measured inflammatory markers.

    CBCHCV rawdata. This file contains the raw dataset used in the analysis of decreased levels of inflammatory markers in patients with hepatitis C virus (HCV) infection. The dataset... by Lu Han (151620)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 273
    Predicted probability of infection symptoms due to forest cover for 2011 and 2016.

    Predicted probability of infection symptoms due to forest cover for 2011 and 2016. by Amit Timilsina (15203538)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 274
    Study variables.

    Study variables. by Amit Timilsina (15203538)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 275
    Descriptive statistics.

    Descriptive statistics. by Amit Timilsina (15203538)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 276
    NMN improves neurological function and survival after cardiac arrest in mice.

    NMN improves neurological function and survival after cardiac arrest in mice. by Daiki Kaito (12514087)

    Published 2025
    Save to List
    Saved in:
  17. 277
    Microhardness of various samples.

    Microhardness of various samples. by Huashen Guan (20454677)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 278
    Shot peening process parameters.

    Shot peening process parameters. by Huashen Guan (20454677)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 279
    Wear morphology: (a) UT, (b) SP1, (c) SP2, and (d) SP3.

    Wear morphology: (a) UT, (b) SP1, (c) SP2, and (d) SP3. by Huashen Guan (20454677)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 280
    Schematic diagram of pin-disk wear.

    Schematic diagram of pin-disk wear. by Huashen Guan (20454677)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: